. Intact HeLa cells and HeLa cells with knockouts or knockdowns of the depicted on the figure DNA repair factors were subjected to hypoosmotic stress for 30 min and stained with corresponding phospho-specific antibody. Figure S2 . HeLa cells were depleted for either ATM, ATR, DNA-PKcs, CHD4, MTA2, TopBP1, Treacle, ATMIN, or ATRIP using RNA interference or CRISPR/Cas9 technology. Knockdown and knockout efficiencies were analyzed by WB or qRT-PCR. Figure S3 . Hypoosmotic stress induces phosphorylation of histone H2AX. (A) Human (HEK293T, HT1080, normal skin fibroblasts) and mouse (CT26) cells were treated with hypoosmotic stress (OS) for 3 h. WB analysis with antibodies against H2AX was performed. Unmodified histone H2AX was used as a loading control. (B) Viability analysis of HeLa cells subjected to hypo-or hyperosmotic stress. Cells that were either untreated, treated with hypoosmotic stress (150 mOsm/L) for 1 or 3 hours (hypo), or treated with hyperosmotic stress (600 mOsm/L) for 1 hour (hyper) and allowed to recover for the indicated intervals (24 and 48 hours) were assayed for cellular viability using MTT reduction (the absorbance at 570 nm is directly proportional to cell number). Error bars represent the SEM. (C) HeLa cells, untreated or treated either with puromycin (puro; 10 μM, 16 h), hypoosmotic (hypo; 150 or 100 mOsm/L, 3 h), or hyperosmotic stress (hyper; 600 mOsm/L, 3 h), were analyzed using CellEvent Caspase 3/7 Detection Reagent. Percent of caspase 3/7-positive (apoptotic) cells is shown. (D) HeLa cells were pulse-labeled with EdU (10 μM, 30 min), subjected to hypoosmotic stress, and stained for γH2AX (green). EdU was revealed by Click Chemistry (red). Representative S-phase cell is shown. Scale bar: 5 µm. (E) WB analysis of H2AX in G1-and G2-phase HeLa cells pretreated with specific inhibitors of either ATM (KU55933), ATR (VE821) or DNA-PKcs (NU7026) and subjected to hypoosmotic stress for 1 or 3 hours. Unmodified histone H2AX was used as a loading control.
Supplementary
. Hypoosmotic stress leads to nucleoli-specific activation of ATRand ATM-dependent signaling. (A) HeLa cells were subjected to hypoosmotic stress for 3 h and stained for γH2AX (green) and nucleolin (red). The DNA was stained with DAPI (blue). Scale bar: 20 m. (B) Structured illumination microscopy (SIM) analysis of G1-phase HeLa cells that were treated with hypoosmotic stress for 1 h and stained for DDR factors (phospho-Nbs1 (Ser343), TopBP1, phospho-ATM (Ser1981) or phospho-ATR (Thr1989); green) and nucleolar proteins (B23 or Ki67; red). Scale bar: 5 µm. Figure S5 . HeLa cells, untreated or treated either with RNA polymerase II inhibitor 5,6-dichlorobenzimidazole 1-β-D-ribofuranoside (DRB; 50 µM, 3 h) or pol I inhibitor actinomycin D (ACD; 0.01 µg/ml, 3 h), were simultaneously pulsed with FU for 3 h. FU was revealed by immunocytochemistry (red); the DNA was stained with DAPI (blue). Scale bar: 20 µm. Figure S6 . HeLa cells depleted for ATM or ATR were subjected to hypoosmotic stress for 1 h and stained for either TopBP1, phospho-Nbs1 (Ser343), phospho-ATR (Thr1989) or phospho-ATM (Ser1981) (green). The DNA was stained with DAPI (blue); merged representative images are shown. Scale bar: 20 µm.

Supplementary Figure S7.
Treacle is not necessary for TopBP1 recruitment during replication stress. Intact and Treacle knockdown HeLa cells were pulselabeled with EdU (10 μM, 30 min), treated with hydroxyurea (20 mM, 1 h) and immunostained against TopBP1 (green). EdU was revealed by Click Chemistry (red); the DNA was stained with DAPI (blue). Representative S-phase cell is shown. Scale bar: 5 µm. 
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